| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,642 |
1,628 |
$96K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
640 |
635 |
$65K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
878 |
870 |
$45K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
733 |
724 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
191 |
190 |
$15K |
| 99050 |
|
493 |
488 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
195 |
194 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
191 |
190 |
$6K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
253 |
253 |
$2K |
| 0071A |
|
30 |
30 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
70 |
70 |
$718.90 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
33 |
33 |
$674.85 |
| 99051 |
|
17 |
16 |
$510.00 |
| 94760 |
|
248 |
247 |
$505.34 |
| 96127 |
|
16 |
16 |
$164.32 |